Erratum: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer (Oncotarget (2017) 8 (8162–8172) DOI: 10.18632/oncotarget.14131)

Research output: Contribution to journalComment/debate

Abstract

This article has been corrected: In Figure 2B, the C4-2 image in the ‘LV3-miR-218’ column contains an accidental duplication of the CWR22Rv1 image in the same column. The corrected Figure 2, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original languageEnglish
Pages (from-to)507
Number of pages1
JournalOncotarget
Volume13
Issue number1
DOIs
StatePublished - 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Erratum: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer (Oncotarget (2017) 8 (8162–8172) DOI: 10.18632/oncotarget.14131)'. Together they form a unique fingerprint.

Cite this